This online module is made available through funding from the Ministry of Health and Long-Term Care.
Upon completion of this program, participants will be able to:
To receive the letter of completion for this online module, participants will be required to complete the following requirements until August 23, 2019:
As part of your registration to this online module, you will be provided with access to the Take-Home Naloxone: The Clinical Aspects article that will be available under “Additional References” on our online platform. Please note that this supplemental reading is non-accredited.
Pre-requisites and target audience
This online module is designed for community pharmacists who are interested in learning about signs and symptoms of opioid overdose, and how to respond to opioid overdose using naloxone.
There are no pre-requisites for this program.
Last updated: September 25, 2018
Inquiries: Please contact OPA’s professional development team by phone at 416-441-0788, option 3 (toll-free in Ontario at 1-877-341-0788, option 3), or by email at email@example.com.
Protecting your privacy: Your privacy is important to us. Some information you provide to OPA in program registration forms and exercises may be considered personal information. The Association collects, uses, and shares the information contained in program registration forms and exercises for the sole purposes of processing your registration, issuing certificates/letters of completion, awarding continuing education credits, and delivering OPA services, programs, and publications to you.
Learners’ code of conduct: By registering for an OPA education program, you agree to follow OPA’s Learners’ Code of Conduct. For further details click here.
Event Date: Recurring | City: Online | Venue: Online